Biocon Ltd. — Regulatory Filings 2020

Aug 14, 2020

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417

www.biocon.com

Date of submission: August 14, 2020

ToThe SecretaryBSE LimitedDepartment of Corporate ServicesPhiroze Jeejeebhoy Towers,Dalal Street,Mumbai – 400 001	ToThe SecretaryNational Stock Exchange of India LimitedCorporate Communication DepartmentExchange Plaza, Bandra Kurla ComplexMumbai – 400 050
Scrip Code - 532523	Scrip Symbol- BIOCON

Dear Sir/Madam,

Sub: Meetings conducted with Institutional Investors/Research Analysts.

Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meetings were conducted with Institutional Investor / Research Analysts:

Date	Name	Type of meeting	Location
August 13, 2020	Aditya Birla Sunlife Insurance	Virtual GroupConference	Bangalore
	BNP Paribas Mutual Fund
	Dalal & Broacha Securities
	Dalal Broacha AIF
	DSP Mutual Fund
	Habrock Capital
	L&T Mutual Fund
	PNB Metlife Insurance
	SBI Life Insurance
	Tata Mutual Fund
	UTI Mutual Fund
	JP Morgan Asset Management	Teleconference	Bangalore

We request you to kindly take above intimation on record.

Thanking You,

Yours faithfully,

For Biocon Limited

==> picture [97 x 37] intentionally omitted <==

==> picture [77 x 81] intentionally omitted <==

---

Mayank Verma

Company Secretary and Compliance Officer